New Zealand markets open in 7 hours 30 minutes

T2 Biosystems, Inc. (0A57.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
1.8150-0.0300 (-1.63%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.31
52-week change 3-90.15%
S&P500 52-week change 332.65%
52-week high 374.0800
52-week low 31.7950
50-day moving average 35.1000
200-day moving average 315.5510

Share statistics

Avg vol (3-month) 31.85k
Avg vol (10-day) 3354
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 85.12M
% held by insiders 14.45%
% held by institutions 174.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.01:1
Last split date 313 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-490.52%

Management effectiveness

Return on assets (ttm)-90.46%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)7.16M
Revenue per share (ttm)1.00
Quarterly revenue growth (yoy)-0.60%
Gross profit (ttm)N/A
EBITDA -42.13M
Net income avi to common (ttm)-48.26M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.25M
Total cash per share (mrq)0.24
Total debt (mrq)19.22M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.60
Book value per share (mrq)-0.34

Cash flow statement

Operating cash flow (ttm)-43.73M
Levered free cash flow (ttm)-31.85M